3-(3,4-Dihydroxyphenyl)prop-2-enoate

Details

Top
Internal ID d80d9a93-c9ab-42ef-9479-49aa10cb0d92
Taxonomy Phenylpropanoids and polyketides > Cinnamic acids and derivatives > Hydroxycinnamic acids and derivatives > Hydroxycinnamic acids
IUPAC Name 4-(2-carboxyethenyl)-2-hydroxyphenolate
SMILES (Canonical) C1=CC(=C(C=C1C=CC(=O)O)O)[O-]
SMILES (Isomeric) C1=CC(=C(C=C1C=CC(=O)O)O)[O-]
InChI InChI=1S/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/p-1
InChI Key QAIPRVGONGVQAS-UHFFFAOYSA-M
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C9H7O4-
Molecular Weight 179.15 g/mol
Exact Mass 179.03443370 g/mol
Topological Polar Surface Area (TPSA) 80.60 Ų
XlogP 1.80
Atomic LogP (AlogP) 0.56
H-Bond Acceptor 3
H-Bond Donor 2
Rotatable Bonds 2

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 3-(3,4-Dihydroxyphenyl)prop-2-enoate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9455 94.55%
Caco-2 + 0.5000 50.00%
Blood Brain Barrier - 0.7250 72.50%
Human oral bioavailability + 0.7000 70.00%
Subcellular localzation Mitochondria 0.7467 74.67%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9433 94.33%
OATP1B3 inhibitior + 0.9580 95.80%
MATE1 inhibitior - 0.8800 88.00%
OCT2 inhibitior - 1.0000 100.00%
BSEP inhibitior - 0.8835 88.35%
P-glycoprotein inhibitior - 0.9904 99.04%
P-glycoprotein substrate - 0.9787 97.87%
CYP3A4 substrate - 0.7337 73.37%
CYP2C9 substrate - 0.6090 60.90%
CYP2D6 substrate - 0.8750 87.50%
CYP3A4 inhibition - 0.9126 91.26%
CYP2C9 inhibition - 0.8095 80.95%
CYP2C19 inhibition - 0.8379 83.79%
CYP2D6 inhibition - 0.9409 94.09%
CYP1A2 inhibition - 0.9025 90.25%
CYP2C8 inhibition - 0.7110 71.10%
CYP inhibitory promiscuity - 0.8744 87.44%
UGT catelyzed + 0.5362 53.62%
Carcinogenicity (binary) - 0.7666 76.66%
Carcinogenicity (trinary) Non-required 0.6284 62.84%
Eye corrosion - 0.6213 62.13%
Eye irritation + 1.0000 100.00%
Skin irritation + 0.8663 86.63%
Skin corrosion - 0.8648 86.48%
Ames mutagenesis - 0.8400 84.00%
Human Ether-a-go-go-Related Gene inhibition - 0.9044 90.44%
Micronuclear + 0.8300 83.00%
Hepatotoxicity - 0.5851 58.51%
skin sensitisation + 0.7921 79.21%
Respiratory toxicity - 0.6000 60.00%
Reproductive toxicity + 0.7667 76.67%
Mitochondrial toxicity - 0.7000 70.00%
Nephrotoxicity - 0.7862 78.62%
Acute Oral Toxicity (c) III 0.4802 48.02%
Estrogen receptor binding - 0.7295 72.95%
Androgen receptor binding + 0.7738 77.38%
Thyroid receptor binding - 0.5706 57.06%
Glucocorticoid receptor binding - 0.7055 70.55%
Aromatase binding - 0.8453 84.53%
PPAR gamma + 0.5966 59.66%
Honey bee toxicity - 0.9518 95.18%
Biodegradation - 0.5500 55.00%
Crustacea aquatic toxicity - 0.6800 68.00%
Fish aquatic toxicity + 0.9765 97.65%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.33% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 93.13% 95.56%
CHEMBL1293249 Q13887 Kruppel-like factor 5 92.87% 86.33%
CHEMBL3194 P02766 Transthyretin 92.63% 90.71%
CHEMBL1951 P21397 Monoamine oxidase A 90.96% 91.49%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 88.92% 96.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 83.40% 89.00%
CHEMBL3060 Q9Y345 Glycine transporter 2 82.35% 99.17%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 81.07% 94.45%

Cross-Links

Top
PubChem 54710367
NPASS NPC1788